Simply in the past years, scientists have understood the big role that the microbes living inside and on us play in our health. The human microbiome, and especially the gut microbiome, has actually been linked to multiple persistent diseases, including diabetes. An out of balance microbiome structure has been discovered in clients with diabetes, who tend to have a less varied gut microbiome as compared to healthy people. Video Tips.
Some companies are establishing diabetes treatments targeting the microbiome. The French Valviotis is presently performing preclinical testing of a drug focused on increasing the microbiome diversity as a treatment for type 2 diabetes. Although appealing, the microbiome field is really young and its intricacy makes it hard to develop causation after discovering correlation.
That world may not be so far away, as lots of companies are developing non-invasive methods to replace finger pricking. Video Tips. Stability Applications has established a device called GlucoTrack that can determine glucose utilizing electromagnetic waves and is already readily available in Europe. Comparable innovations are popping up, with GlucoSense in London utilizing laser light to determine sugar levels and MediWise utilizing radio waves.
The GlucoWise sensing unit prototypePatches are likewise becoming a popular kind of determining blood glucose without needles, such as FreeStyle Libre, an inch-wide spot that can be used for as much as 2 weeks. At the University of Bath, researchers are establishing a graphene patch that might provide greater precision by measuring sugar levels separately in multiple hair follicles – Video Tips.
On the other hand, Senseonic and Roche are working on a device that is implanted under the skin. Video Tips. Still, non-invasive choices to measure blood glucose frequently face problems relating to precision. The popular glucose-measuring contact lens that Google revealed in 2014 was dismissed as “technically infeasible” and further advancements will be required to reach the degree of precision of finger-pricking methods.
Scientists are already hypothesizing about microchips that can diagnose diabetes type 1 before the symptoms appear or nanorobots traveling in the blood stream while they measure glucose and provide insulin – Video Tips.”There’s little fiction left in this. I highly believe that microrobotics will come and will be part of our drug delivery within the next ten years,” stated Tomas Landh, Director of Method and Innovation Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Yearly MeetingWhatever the future brings, it will undoubtedly make a huge difference in the lives of millions of people worldwide.